San Diego-based Viking Therapeutics marked alone as a significant competitor inside the weight loss drug market in February soon after revealing promising info from the mid-stage demo of experimental drug VK2735, which recommended it rivaled—and outperformed—Novo and Lilly drugs when presented for a weekly injection As well as in March the comp
who makes the diabetes drug copyright No Further a Mystery
In March 2025, the company announced new programs for just a immediate-to-shopper featuring of its Wegovy weight loss drug. The company established a whole new pharmacy, identified as NovoCare, which might cost buyers $499 per month for use of the drug, a lot less than 50 percent the price of the drug as a result of other pharmaceutical distributio